Deregulation of intestinal anti-microbial defense by the dietary additive, maltodextrin

Gut Microbes

Volumn 6, Issue 1, 2015, Pages 78-83

  Nickerson, Kourtney P ^a,b   Chanin, Rachael ^a   McDonald, Christine ^c,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anti microbial defense; Crohn s disease; Diet; Dietary additive; Inflammatory bowel disease; Intestinal homeostasis; Maltodextrin; Mucosal defense

Indexed keywords

CARBOXYMETHYLCELLULOSE; CARRAGEENAN; IMMUNOGLOBULIN A; MALTODEXTRIN; MUCIN 2; XANTHAN; FOOD ADDITIVE; IMMUNOSUPPRESSIVE AGENT; POLYSACCHARIDE;

ARTICLE; BACTERIAL LOAD; CARBOHYDRATE DIET; CARBOHYDRATE METABOLISM; CROHN DISEASE; DEFENSE MECHANISM; DEREGULATION; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FLUORESCENCE IN SITU HYBRIDIZATION; FOOD AVAILABILITY; FOOD FREQUENCY QUESTIONNAIRE; GLYCOSYLATION; HEALTH CARE; HEREDITY; HOMEOSTASIS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; INCIDENCE; INFLAMMATORY BOWEL DISEASE; INTESTINAL HOMEOSTASIS; INTESTINE FLORA; META ANALYSIS (TOPIC); MUCOSAL HOMEOSTASIS; NONHUMAN; PATHOGENESIS; PHENOTYPE; ULCERATIVE COLITIS; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; IMMUNOLOGY; INTESTINE MUCOSA; MUCOSAL IMMUNITY;

BACTERIA (MICROORGANISMS);

ANIMALS; FOOD ADDITIVES; HUMANS; IMMUNITY, MUCOSAL; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; POLYSACCHARIDES;

EID: 84924712097     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.1080/19490976.2015.1005477     Document Type: Article

References (45)

1. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol 2010; 28:573-621. PMID:20192811; http://dx.doi.org/10.1146/annurev-immunol-030409-101225.
2. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA. et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491:119-24. PMID:23128233; http://dx.doi.org/10.1038/nature11582.
3. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW., et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142:46-54 e42; quiz e30. PMID:22001864; http://dx.doi.org/10.1053/j.gastro.2011.10.001.
4. Rogler G, Vavricka S. Exposome in IBD: recentinsights in environmental factors that influence theonset and course of IBD. Inflamm Bowel Dis 2014; 21:400-8. PMID:25358064; http://dx.doi.org/10.1097/MIB.0000000000000229.
5. Spooren CE, Pierik MJ, Zeegers MP, Feskens EJ, Masclee AA, Jonkers DM. Review article: the association of diet with onset and relapse in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2013; 38:1172-87. PMID:24118051; http://dx.doi.org/10.1111/apt.12501.
6. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2006; 134:577-94. PMID:18242222; http://dx.doi.org/10.1053/j.gastro. 2007.11.059.
7. Walters WA, Xu Z, Knight R. Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett 2014; 588:4223-33. PMID:25307765; http://dx.oi.org/10.1016/j.febslet.2014.09.039.
8. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, Bringer MA, Swidsinski A, Beaugerie L, Colombel JF. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease. Gastroenterology 2004; 127:412-21. PMID:15300573; http://dx.doi.org/10.1053/j.gastro.2004.04.061.
9. Chronakis IS. On the molecular characteristics, compo-sitional properties, and tructural-functional mechanisms of maltodextrins: a review. Crit Rev Food Sci Nutr 1998; 38:599-637. PMID:9813736; http://dx.doi.org/10.1080/10408699891274327.
10. Economic Research Service (ERS), US Department of Agriculture (USDA). Food Availability (Per Capita)Data System, 2010. Retrieved from http://ers.usda.gov/data-products/food-availability-(per-capita)-data-system.aspx.
11. FDA. Title 21, volume 3, part 184, subpart B, section184.1444. Three Code of Federal Regulations..
12. Brown K, DeCoffe D, Molcan E, Gibson DL. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients 2012; 4:1095-119. PMID:23016134; http://dx.doi.org/10.3390/nu4081095.
13. Flint HJ, Scott KP, Louis P, Duncan SH. The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol 2012; 9:577-89. PMID:22945443; http://dx.doi.org/10.1038/nrgastro.2012.156.
14. Ivanov II, Littman DR. Segmented filamentous bacteria take the stage. Mucosal Immunol 2010; 3:209-12. PMID:20147894; http://dx.doi.org/10.1038/mi.2010.3.
15. Kunisawa J, Kiyono H. Vitamins mediate immunologi-cal homeostasis and diseases at the surface of the body. Endocr Metab Immune Disord Drug Targets 2014; Oct21 [Epub ahead of print]. PMID:25335990; http://dx.doi.org/10.2174/1871530314666141021114651.
16. Stowe SP, Redmond SR, Stormont JM, Shah AN, Chessin LN, Segal HL, Chey WY. An epidemiologic study of inflammatory bowel disease in rochester, new york. hospital incidence. Gastroenterology 1990; 98:104-10. PMID:2293567..
17. McDonald DE, Pethick DW, Mullan BP, Hampson DJ. Increasing viscosity of the intestinal contents alters small intestinal structure and intestinal growth, and stimulates proliferation of enterotoxigenic escherichia coli in newly- weaned pigs. Br J Nutr 2001; 86:487-98. PMID:11591236; http://dx.doi.org/10.1079/BJN2001416.
18. Thymann T, Moller HK, Stoll B, Stoy AC, Buddington RK, Bering SB, Jensen BB, Olutoye OO, Siggers RH, Molbak L., et al. Carbohydrate maldigestion induces necrotizing enterocolitis in preterm pigs. Am J Physiol Gastrointest Liver Physiol 2009; 297:G1115-25. PMID:19808655; http://dx.doi.org/10.1152/ajpgi.00261.2009.
19. Lapaquette P, Glasser AL, Huett A, Xavier RJ, Darfeuille-Michaud A. Crohn’s disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol 2010; 12:99-113. PMID:19747213; http://dx.doi.org/10.1111/j.1462-5822.2009.01381.x.
20. Martinez-Medina M, Aldeguer X, Lopez-Siles M, Gonzalez-Huix F, Lopez-Oliu C, Dahbi G, Blanco JE, Blanco J, Garcia-Gil LJ, Darfeuille-Michaud A. Molecular diversity of escherichia coli in the human gut: new ecological evidence supporting the role of adherent- invasive E. coli (AIEC) in crohn’s disease. Inflamm Bowel Dis 2009; 15:872-82. PMID:19235912; http://dx.doi.org/10.1002/ibd.20860.
21. Swidsinski A, Loening-Baucke V, Herber A. Mucosal flora in crohn’s disease and ulcerative colitis - an over-view. J Physiol Pharmacol 2009; 60 6:61-71. PMID:20224153.
22. Nickerson KP, McDonald C. Crohn’s disease-associated adherent-invasive escherichia coli adhesion is enhanced by exposure to the ubiquitous dietary polysaccharide maltodextrin. PLoS One 2012; 7:e52132. PMID:23251695; http://dx.doi.org/10.1371/journal.pone.0052132.
23. Nickerson KP, Homer CR, Kessler SP, Dixon LJ, Kabi A, Gordon IO, Johnson EE, de la Motte CA, McDonald C. The dietary polysaccharide maltodextrin promotes Salmonella survival and mucosal colonization in mice. PLoS One 2014; 9:e101789. PMID:25000398; http://dx.doi.org/10.1371/journal.pone.0101789.
24. Muise AM, Xu W, Guo CH, Walters TD, Wolters VM, Fattouh R, Lam GY, Hu P, Murchie R, Sherlock M., NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2. Gut 2012; 61:1028-35. PMID:21900546; http://dx.doi.org/10.1136/gutjnl-2011-300078.
25. Roberts RL, Hollis-Moffatt JE, Gearry RB, Kennedy MA, Barclay ML, Merriman TR. Confirmation of association of IRGM and NCF4 with ileal crohn’s disease in a population-based cohort. Genes Immun 2008; 9:561-5. PMID:18580884; http://dx.doi.org/10.1038/gene.2008.49.
26. Moyana TN, Lalonde JM. Carrageenan-induced intestinal injury in the rat-a model for inflammatory bowel disease. Ann Clin Lab Sci 1990; 20:420-6. PMID:2073092..
27. Swidsinski A, Ung V, Sydora BC, Loening-Baucke V, Doerffel Y, Verstraelen H, Fedorak RN. Bacterial over-growth and inflammation of small intestine after carboxymethylcellulose ingestion in genetically susceptible mice. Inflamm Bowel Dis 2009; 15:359-64. PMID:18844217; http://dx.doi.org/10.1002/ibd.20763.
28. Beal J, Silverman B, Bellant J, Young TE, Klontz K. Late onset necrotizing enterocolitis in infants following use of a xanthan gum-containing thickening agent. J Pediatr 2012; 161:354-6. PMID:22575248; http://dx.doi.org/10.1016/j.jpeds.2012.03.054.
29. Woods CW, Oliver T, Lewis K, Yang Q. Development of necrotizing enterocolitis in premature infants receiving thickened feeds using simplythick(R). J Perinatol 2012; 32:150-2. PMID:22289705; http://dx.doi.org/10.1038/jp.2011.105.
30. Swidsinski A, Sydora BC, Doerffel Y, Loening-Baucke V, Vaneechoutte M, Lupicki M, Scholze J, Lochs H, Dieleman LA. Viscosity gradient within the mucus layer determines the mucosal barrier function and the spatial organization of the intestinal microbiota. Inflamm Bowel Dis 2007; 13:963-70. PMID:17455202; http://dx.doi.org/10.1002/ibd.20163.
31. Johansson ME, Gustafsson JK, Sjoberg KE, Petersson J, Holm L, Sjovall H, Hansson GC. Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model. PLoS One 2010; 5:e12238. PMID:20805871; http://dx.doi.org/10.1371/journal.pone.0012238.
32. Johansson ME. Mucus layers in inflammatory bowel disease. Inflamm Bowel Dis 2014; 20:2124-31. PMID:25025717; http://dx.doi.org/10.1097/MIB.0000000000000117.
33. van der Post S, Subramani DB, Backstrom M, Johansson ME, Vester-Christensen MB, Mandel U, Bennett EP, Clausen H, Dahlen G, Sroka A., Site-specific O- glycosylation on the MUC2 mucin protein inhibits cleavage by the porphyromonas gingivalis secreted cysteine protease (RgpB). J Biol Chem 2013; 288:14636-46. PMID:23546879; http://dx.doi.org/10.1074/jbc.M113.459479.
34. Mastrodonato M, Mentino D, Portincasa P, Calamita G, Liquori GE, Ferri D. High-fat diet alters the oligo-saccharide chains of colon mucins in mice. Histochem Cell Biol 2014; 142:449-59. PMID:24770665; http://dx.doi.org/10.1007/s00418-014-1221-2.
35. Martinez-Medina M, Denizot J, Dreux N, Robin F, Billard E, Bonnet R, Darfeuille-Michaud A, Barnich N. Westerndiet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation. Gut 2014; 63:116-24. PMID:23598352; http://dx.doi.org/10.1136/gutjnl-2012-304119.
36. Garcia Rodriguez LA, Ruigomez A, Panes J. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology 2006; 130:1588-94. PMID:16697722; http://dx.doi.org/10.1053/j.gastro.2006.02.004.
37. Chassaing B, Koren O, Carvalho FA, Ley RE, Gewirtz AT. AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition. Gut 2014; 63:1069-80. PMID:23896971; http://dx.doi.org/10.1136/gutjnl-2013-304909.
38. Small CL, Reid-Yu SA, McPhee JB, Coombes BK. Persistent infection with crohn’s disease-associated adherent-invasive escherichia coli leads to chronic inflammation and intestinal fibrosis. Nat Commun 2013; 4:1957. PMID:23748852; http://dx.doi.org/10.1038/ncomms2957.
39. Cohen SA, Gold BD, Oliva S, Lewis J, Stallworth A, Koch B, Eshee L, Mason D. Clinical and mucosal improvement with specific carbohydrate diet in pediatric crohn disease. J Pediatr Gastroenterol Nutr 2014; 59:516-21. PMID:24897165; http://dx.doi.org/10.1097/MPG.0000000000000449.
40. Olendzki BC, Silverstein TD, Persuitte GM, Ma Y, Baldwin KR, Cave D. An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report. Nutr J 2014; 13:5. PMID:24428901; http://dx.doi.org/10.1186/1475-2891-13-5Gut Microbes.
41. Suskind DL, Wahbeh G, Gregory N, Vendettuoli H, Christie D. Nutritional therapy in pediatric crohn disease: the specific carbohydrate diet. J Pediatr Gastroenterol Nutr 2014; 58:87-91. PMID:24048168; http://dx.doi.org/10.1097/MPG.0000000000000103.
42. Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA, O’Keefe JH, Brand-Miller J. Origins and evolution of the western diet: health implications for the 21st century. Am J Clin Nutr 2005; 81:341-54. PMID:15699220..
43. Kakodkar SM, Engen P, Mutlu E. The bacterial microbiome of IBD patients on the specific carbohydrate diet (SCD). Am J Gastroenterol 2013; 108:S552; http://dx.doi.org/10.1038/ajg.2012.470.
44. Dixon LE, Kabi A, Nickerson KP, McDonald C. Combinatorial effects of diet and genetics on inflammatory bowel disease pathogenesis. Inflamm Bowel Dis 2015; Jan 9 [Epub ahead of print]. PMID: 25581832; http://dx.doi.org/10.1097/MIB/0000000000000289.
45. Korn LL, Thomas HL, Hubbeling HG, Spencer SP, Sinha R, Simkins HM, Salzman NH, Bushman FD, Laufer TM. Conventional CD4C T cells regulate IL- 22-producing intestinal innate lymphoid cells. Mucosal Immunol 2014; 7:1045-57. PMID:24448096; http://dx.doi.org/10.1038/mi.2013.121.